title: Microbicide vaginal rings: Technological challenges and clinical development.
abstract: Vaginal rings (VRs) are flexible, torus-shaped, polymeric devices designed to sustain delivery of pharmaceutical drugs to the vagina for clinical benefit. Following first report in a 1970 patent application, several steroid-releasing VR products have since been marketed for use in hormone replacement therapy and contraception. Since 2002, there has been growing interest in the use of VR technology for delivery of drugs that can reduce the risk of sexual acquisition of human immunodeficiency virus type 1 (HIV-1), the causative agent of acquired immunodeficiency syndrome (AIDS). Although no vaginally-administered product has yet been approved for HIV reduction/prevention, extensive research efforts are continuing and a number of VR devices offering sustained release of so-called 'HIV microbicide' compounds are currently being evaluated in late-stage clinical studies. This review article provides an overview of the published scientific literature within this important field of research, focusing primarily on articles published within peer-reviewed journal publications. Many important aspects of microbicide-releasing VR technology are discussed, with a particular emphasis on the technological, manufacturing and clinical challenges that have emerged in recent years.
authors.affiliation: School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK. Electronic address: k.malcolm@qub.ac.uk.
authors.forename: R Karl
authors.initials: RK
authors.lastname: Malcolm
authors.affiliation: School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Boyd
authors.affiliation: School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK.
authors.forename: Clare F
authors.initials: CF
authors.lastname: McCoy
authors.affiliation: School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK.
authors.forename: Diarmaid J
authors.initials: DJ
authors.lastname: Murphy
mesh_terms: D000890:Anti-Infective Agents; D003274:Contraceptive Devices, Female; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans
chemical_list: D000890:Anti-Infective Agents
keywords: Adherence; Antiretrovirals; Controlled release; HIV microbicides; HIV prevention; Vaginal drug delivery; Vaginal rings